Intestinal microbiota transplantation: a potential new therapy for colorectal cancer

Although it is known that the human gut is colonized by a wide variety of microbial populations, many effects of the complex interactions between the human host and microbial symbionts are still not completely understood. The dysbiosis or microbial imbalance of the gastrointestinal tract microbiota is considered to be one of the most important contributing factors in the development of many gastrointestinal diseases such as inflammatory bowel disease, irritable bowel syndrome and colorectal cancer. This project uses high throughput genomic methods to characterize the microbiota in healthy and diseased mouse gut. It also investigates whether normal gut flora can be restored by fecal microbiota transplantation.

Faculty Supervisor:

Guido van Marle

Student:

Partner:

Harbin Medical University

Discipline:

Life Sciences

Sector:

Education

University:

University of Calgary

Program: